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Summary. Using poly(lactide-co-glycolide) (PLGA) particles for drug encapsula-
tion and delivery has recently gained considerable popularity for a number of rea-
sons. An advantage in one sense, but a drawback of PLGA use in another, is that
drug delivery systems made of this material can provide a wide range of dissolution
profiles, due to their internal structure and properties related to particles’ manu-
facture. The advantages of enriching particulate drug design experimentation with
computer models, are evident with simulations used to predict and optimize design,
as well as indicate choice of best manufacturing parameters. In the present work,
we seek to understand the phenomena observed for PLGA micro- and nanospheres,
through Cellular Automata (CA) agent-based Monte Carlo (MC) models. Systems
are studied both over large temporal scales, (capturing slow erosion of PLGA) and
for various spatial configurations (capturing initial as well as dynamic morphology).
The major strength of this multi-agent approach is to observe dissolution directly, by
monitoring the emergent behaviour: the dissolution profile manifested, as a sphere
erodes. Different problematic aspects of the modelling process are discussed in de-
tails in this paper. The models were tested on experimental data from literature,
demonstrating very good performance. Quantitative discussion is provided through-
out the text in order to make a demonstration of the use in practice of the proposed
model.
Keywords: drug delivery, PLGA, microspheres, nanospheres, dissolution, mod-
elling, multi-agents, simulation, Monte Carlo, Cellular Automata.
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1 Introduction
Nano- and microspheres are particulate drug delivery systems (DDS) of
nanometer or micron size ranges respectively, consisting of bioerodible solids,
which can incorporate therapeutic agents, such as small drugs or macro-
molecules [1]. During the last decades, particulates have evolved from an
alternative experimental type of sustained delivery to a prominent class of
DDS with various applications and many promising future developments [2].
Currently, polymeric particulates have found applications in many key bio-
engineering fields such as: bone repair, tissue engineering and development
[1, 3, 4], and biomedical applications like vaccine delivery, various treatments
for cancer, AIDS, tuberculosis and other diseases [5, 6, 7, 8].
One of the most successful polymers, used in the production of particulates
for controlled release is PLGA. An advantage of this polymer is that bio-
compatible and biodegradable products of dissolution of the particles do not
require further manipulation after introduction to the body. Besides the fact
that it is non-toxic (PLGA nanospheres can be 16 times more effective for
cell viability than the free drug, [5]), this material has proved capable of easy
encapsulation [5] and subsequent release of drug (especially of pharmaceuti-
cally active proteins), in a sustained manner. Experimental studies such as
[5, 9, 10] demonstrate the potential for encapsulation and sustained release of
a wide variety of proteins from PLGA spheres.
PLGA belongs to the group of bulk eroding polymers. These polymers erode
slowly and water uptake by the system is much faster than polymer degrada-
tion. In this case, erosion is not restricted to the polymer surface, because the
entire system is rapidly hydrated and polymer chains are cleaved throughout
the device [11]. This mechanism permits using PLGA in controlled-release
applications.
Title Suppressed Due to Excessive Length 3
Another reason for the success of PLGA in particle manufacture is the versa-
tility of its release properties, which can be modified by varying composition
(lactide/glycolide ratio), molecular weight and chemical structure. In this way,
a wide range of in vivo life-times of PLGA can be obtained: from three weeks
to over a year [1]. On the other hand, release profiles are also significantly
influenced by the method of microencapsulation [1, 3], because the latter is
at the origin of obtaining one or another internal morphology of the particles.
While one method results in the protein solid dispersion within the polymeric
matrix (Figure 1, (a)), others yield structures where the protein can be located
in the occlusions and large pores, formed during the production of spheres [1],
Figure 1, (b). With the downside that total control of the pore sizes is still
not possible, some studies, such as [3], mention good results such as control
over the order of pore dimension.
Fig. 1. a) Sphere morphology obtained by the solid-in-oil-in-water solvent evapo-
ration technique. b) Sphere morphology obtained by water- in-oil-in-water solvent
evaporation technique. Adapted from [1].
To date, the biomedical potential of polymeric particulate formulations is far
from being fully explored [2]: the area is growing and expanding, but not as
rapidly as it has potential for. Applications require concomitantly highly spe-
cific, nontoxic and functional solutions, characterised by delivery times rang-
ing from weeks to months, which make experimental research in particulates
extremely time- and resource-intensive. In this context, complementing exper-
4 Ana Barat, Martin Crane and Heather J. Ruskin
imentation with modelling and simulation can be both a scientific challenge
and an economically viable solution. There are currently few reports deal-
ing with investigation of different modelling techniques for protein dissolution
from PLGA spheres. Most adapt differential equation methods to describe the
concentrations of diffusing molecular species at different space and time points
[12, 13, 14]. Continuous and homogeneous morphology-related variables are
required to establish grids for solving the partial differential equations nu-
merically. However, as noted, the particle environment is usually discrete and
heterogeneous. In order to adapt to the porous environment of microspheres,
(which depends on initial porosity and its time-dependent growth), methods
use estimates for global parameters such as porosity (ǫ) and tortuosity (τ),
which ultimately affect drug diffusion coefficient D, e.g. [12, 14].
A break through in modelling the increased complexity in the drug delivery
field was achieved by the class of Cellular Automata (CA) and Monte Carlo
(MC) based microscopic models. In early work of Göpferich and Zygourakis
[4, 15, 16, 17, 18], the polymer, together with the dissolution medium around
it, is represented as a probabilistic cellular automaton: the DDS is mapped
on a computational grid of discrete sites filled with polymer, which degrades
according to a set of rules. Subsequently, [12] Siepmann et al. proposed a
partial differential equation model, coupled with a MC simulator. Although
sounding very promising, the authors’ feeling is the CA and MC models have
not been exploited to their full potential in the area.
Almost all known modelling approaches available [11, 12, 14] consider homo-
geneous distributions of the pores and of proteins in the spheres, experiments
have indicated that this may not realistically describe the majority of cases
[9, 19], with internal configuration of the spheres subject to heterogeneity.
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[9] reveals that spheres enclosing smaller proteins appear to have an open
branched network throughout. However, those enclosing larger proteins have
pores in the outer layers and appeared open near the surface, while having a
more dense structure in the inner layers of the sphere.
Fig. 2. a) Control PLGA sphere, no encapsulated molecules b) PLGA sphere
encapsulating carbonic anhydrase, adapted from [9].
In further discussion of microspheres properties, [13] assumes that adsorption
of macromolecules to the surface of the microsphere (or to the large occlusions
inside the spheres), suggesting an uneven distribution of the macromolecule
in the volume of the sphere.
Even if the internal morphology of the spheres was showed to be heteroge-
neous and to influence the final dissolution profile, no CA and MC modelling
work, specifically taking it into consideration has, to the author’s knowledge,
previously been reported.
In the present paper, we depart from the idea that, for dissolution of pro-
teins from PLGA delivery systems, both pre-existent and dynamically formed
pores influence directly the resulting release profile. Hence, the aim was to
simulate explicitly and simultaneously both PLGA erosion and protein disso-
lution process. The innovative features of this work, the authors believe, lie
in the following: multiple agents to model both protein and their PLGA en-
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vironment, very fine-grained modelling of the spheres, using complementary
data to model the spheres’ 3D internal morphologies and an user-accessible
quantitative calibration.
2 Modelling
The dimensions of the experimental entities involved range from several
nanometers (proteins) to several microns (spheres). A comparatively sim-
ple protein example like the lysozyme (13.4 kDa), has a diameter of 3.2 nm
[20]. Diffusion measurements in PLGA micro- and nanospheres encapsulating
lysozymes involve pore sizes < 20 nm [9], so it was reasonable to describe
diffusion in terms of individual random walks of molecules, rather than by
transport of matter through surfaces. Experimental studies [9], have revealed
that, in general, the initial pores have 5 - 80 nm in diameter, (proportional
to the size of the encapsulated proteins). Equally, other experimental stud-
ies have reported cases of spheres with initial occlusions much larger than the
Stokes-Einstein diameter of the microencapsulated molecule [3, 13]. Neverthe-
less, as long as the proteins undergo very restricted diffusion through pores,
it is appropriate to treat diffusion by individual random walks of a given
number of agents [21, 22]. In such cases, multi-agent systems seem reasonable
approximations for a "protein - PLGA - pore" system.
The assumptions which apply to all models developed here are based on avail-
able experimental data [9]. The polymeric particles, modelled in 3D space, are
considered to be completely spherical. The spheres are discretised throughout
the volume into small sites. Figure 3 represents a schematic diagram of a sec-
tion through a sphere during the simulation. The sites are seeded, according
to predefined initial patterns, with elements such as PLGA polymer or protein
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molecules. If necessary, an initial porosity value in the PLGA bulk material
can be considered and, over time, more pores are formed.
The approach taken here to model the polymer erosion was based on Göpferich’s
theory for polymer erosion [16]. Events which occur independently with some
average rate k are modelled by a Poisson process. It was assumed that the
chain cleavage is a random event following Poisson kinetics. Considering that
a site on the lattice erodes as a result of several Poisson processes which take
place in parallel, the whole process is again a Poisson process. The waiting
times t between k occurrences of the Poisson event are Erlang distributed.
f(t, k, λ) =
λktk−1e−λx
(k − 1)!
(1)
In Equation (1) k and λ are the shape and the rate parameters respectively.
When k=1, the distribution becomes an exponential distribution for a positive
variable, used to model the times between events that happen at a constant
average rate:
f(t, λ) = λe−λt (2)
If the lifetimes of the sites are distributed according to Equation (2), then the
mean lifetime of a single bond is given by t = 1λ .
In practice, the lifetime t can be computed using the following relation:
t =
1
λ
ln(U) (3)
where U is a random number, uniformly distributed between 0 and 1 [16].
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As dissolution proceeds, the lifetimes of the polymer sites begin to decrease.
When a lifetime reaches zero the polymer from this site is considered eroded
and the site becomes a pore. This approach permits the derivation of a rela-
tionship between real time and MC time through λ, the inverse of the mean
lifetime of a PLGA particle, expressed in s−1.
A protein molecule can leave its initial location only in the case where one
of the neighbouring sites is a pore, (i.e. the molecules can only move through
pores). Once in a porous channel, a molecule cannot leave it, except by escap-
ing the sphere, when itis counted as dissolved. The internal configuration of
the spheres in the model can be varied, depending on the internal morphology
of the experimental spheres. In this way, the user can choose a model variant
which addresses the problem most directly. Variants might be:
• homogeneous distribution of entities in the sphere
• stratified distribution of pores and/or concentrations of proteins
• structure with occlusions filled with proteins.
A more detailed description about modelling the internal morphology of the
spheres is given in a parallel paper [23].
Fig. 3. Simplified scheme representing the main characteristics of the multi-agent
model. Cross section through a 3D sphere.
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3 Results and discussion
In this section, unless otherwise specified, the lifetimes of the PLGA par-
ticles were updated every 10 minutes, corresponding to the MC time-step,
and samples were collected every 144 MC steps, (corresponding to one day).
The number of particles per site was sampled from a uniform distribution
between a lower and an upper value: U(a1, a2), a1 < a2. The Von Neumann
neighbourhood was used.
3.1 Effect of Erosion Rate
Modern electron microscopy is able to provide information on pore formation
[9, 13], therefore the rate of formation of pores of a certain size can be de-
termined. The size of a site may be chosen to be in the dimensional range of
the Stokes-Einstein protein diameter, or, for a coarser grained simulation, set
equal to the average size of the initial pores. Thus, the mean lifetime of the
sites depends on these initial assumptions and corresponding model choices.
Figure 4, (a) represents the dynamics of porosity formation for spheres having
a diameter of 80 sites and zero initial porosity. At every step, site lifetimes
are decreased by ∆t=10 minutes.
Clearly, lifetime influences the pattern of porosity dynamics, which is basically
hyperbolic, but may be considered linear in the first 15-20 days. This agrees
with [13], where porosity was found to grow linearly with time for the first 15
days of degradation of PLGA spheres. The figure shows that for λ=0.00002
min−1, (i.e. 1λ=t=34 days) the porosity of the sphere increases from 0 to 0.8
over 55 days, (a typical experimental life-span of PLGA spheres). In this case,
the pores appear quite quickly and result in a sponge-like topology of the
system.
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Fig. 4. a) Evolution of sphere porosity with time; porosity was computed using
a zero-order Erlang distribution life-time approach b) Mean lifetime 1
λ
used in MC
simulations as a function of the porosity growth rate.
Figure 4, (b) represents an empirical relationship deduced between the param-
eter λ and the initial rate of pore formation. The rate was calculated using
the linear part of the porosity dynamics curve (first 20 days). The authors
suggest the idea, that if imaging techniques permit to identify the rate of
porosity growth then Figure 4, (b) can be constructed for the needed sphere
size and the parameter λ for quantitative simulations extrapolated.
Figure 5, shows how porosity growth dynamics can affect the release of
molecules from a sphere. The same spheres used for obtaining Figure 4 have
been seeded randomly with particles, having overall concentration c = 0.02.
The release profiles obtained correspond to typical experimental profiles of re-
lease of macromolecules from PLGA spheres [9, 10]. In all cases, a short initial
burst was observed, corresponding to the release of the particles situated on
the surface of the sphere.
For each particle, the rate parameter, λ, affects the time during which it
remains trapped in the PLGA. Thus, t = 1λ is inversely proportional to the
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rate of release of the molecules, mainly affecting the convexity of the release
curve. With different lifetimes for the input, the model can generate profiles
such as those found in [9, 10].
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Fig. 5. Release profiles as a function of the degradation rate λ.
3.2 Effect of the distribution of drug particles in the sphere
We have verified the effect of initial loading on the emergent dissolution pro-
files. To do this, we have investigated the effects of the following two initial
settings:
• the distribution of macromolecules per site on the dissolution profiles
• the initial protein loading
To examine the first case, the proportion of sites loaded with drug, was kept
constant; while the number of particles per site was varied. For each run, a2
was increased. The particles released were considered in terms of the fraction
of the initial number of particles in the sphere. Unexpectedly the simulations
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predicted that as a2 increases, the fraction of the released drug does not
significantly vary.
To examine the effect of the initial protein loading, the sphere loadings were
considered in terms of percentage of sites on the lattice, containing one or
more particles. Experimental work has shown that an increase in drug load-
ing results in a corresponding increase in the release rate [9, 10]. Sandor et
al. have measured the protein loadings, as a percentage of the total weight of
the nanospheres. The values considered as low loadings were 0.5-1.6 % while
high loadings of protein were 4.8-6.9 % [9]. Thus, to examine the effects of
the initial loadings in a sensitivity analysis framework, concentrations close to
experimental loadings were considered. Figure 6 shows the effect of the initial
concentration on spheres having a diameter d=100 sites and mean lifetime 1λ
=69.4 days (λ=0.00001). Again, no significant effect was evident from modi-
fication of the loading value, i.e. concentration appears to have no significant
influence on the dissolution profiles. Initially, this seems to be inconsistent
with experiment, but, as shown in the following section, the shape of the dis-
solution profile, for all concentrations, is in fact given by the initial porosity
p.
3.3 Initial porosity and initial macromolecular loading
In agreement with our simulations [9] suggest that the increase in the release
rate at higher loadings actually occurs due to initial porosity: at low loadings
(0.5 -1.6 %), small proteins seem to depend on diffusion through pores initially
and on degradation at later times. Spheres with higher loadings are found to
have more interconnecting channels. Sandor et al. consider the channels to be
the reason why the higher-loaded spheres (4.8-6.9 %) do not exhibit the pro-
nounced shift from diffusion-based to polymer erosion-based release seen with
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Fig. 6. For three different initial porosities, p01=0.05, p02=0.2, p03=0.5, the disso-
lution profile was calculated using two values of the initial concentration, c01=0.02
and c02=0.15. Other model inputs: d=100, λ=0.00001, ∆t=10 min, from 1 to 4
particles per site, (von Neumann neighbourhood).
the lower loaded spheres. Although [9] do not provide quantitative evidence of
the increase in interconnecting pores and channels with initial protein loading,
they clearly indicate that not only has the molecular weight of the protein an
obvious effect on the initial porosity, (since larger proteins correlate to larger
pores formed in the carrier spheres), but so has protein loading, (as larger
loadings correlate with larger initial porosities). This supports our finding
that the modifications in protein concentration influence the dissolution pro-
files only indirectly, by modifying the initial porosities of the PLGA-protein
structures obtained. The authors suggest that quantitative studies, investi-
gating how the protein loadings influence the structure of the final spheres,
would help create better models for predictions in drug design.
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Fig. 7. Dissolution profile for different values of the initial porosity. Model inputs:
d=100, λ=0.00001, ∆t=10 min, c0=0.02, from 1 to 4 particles per site, von Neumann
neighbourhood.
Figure 7 shows the reaction to porosity modification for a sphere (d=100
and λ=0.00001), loaded with particles homogeneously distributed throughout
its volume (c0=0.02). As can be observed, even quite small variations of the
initial porosity result in different dissolution profiles beginning with ∼ day 1
of dissolution.
There appears to be a threshold value for the initial porosity, pth, which
separates two different types of dissolution behavior. For p<pth two distinct
dissolution phases can be observed, suggested by the change of shape (from
convex to concave) of the release curve:
1. A first phase, corresponding to dissolution governed by diffusion through
the initial pores.
2. A second phase where diffusion is generated by two processes: dissolu-
tion through the initial pores in conjunction with diffusion through pores
created by the erosion process.
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In the case of Figure 7, pth ≈ 0.3. The first phase ends around day 15. Be-
tween day 1 and day 15, the dissolution rate is constant and depends on the
initial porosity. The second phase begins after day 15 and continues until the
molecules are completely released from the spheres, around day 60. The dis-
solution profiles obtained for p<0.3 follow the same pattern as the lysozyme
and the carbonic anhydrase at ≃1.5% initial loading from [9].
For p0 > pth, there no distinct phases of dissolution were observed. In Figure
7, for pth ≈ 0.3, the profiles obtained have a kinetic pattern as for lysozyme,
c0=6%, alcohol dehydrogenase (1.1 % and 6.9 %) and thyroglobulin (0.5%
and 4.8 %), from [9].
3.4 Quantitative discussion for the use of MC time step
One of the advantages of this work was cited as the fact that the protein
dissolution in the heterogeneous porous environment of the PLGA spheres was
taken into consideration directly, without passing through global parameters
like the global porosity and the global tortuosity, in spite of knowing the
structure of our spheres varies locally. However, working with a direct MC
model brings the challenge of quantifying it.
The target of this section was to establish a relation between the diffusion
coefficient of an encapsulated species in the matrix and the time interval ∆t,
determining the frequency that the model particles are updated.
In their article, Zhang et al. [14] mention two diffusivities: D0 which is the
solute diffusion coefficient in the solvent and Deff the effective solute diffusion
coefficient in the polymer matrix, depending on the internal morphology of
the latter. Based on this work, the following empirical expression gives the
effective diffusivity of a chemical species in a porous medium:
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Deff ∼
D0p
τ
(4)
p is the porosity and τ is the dimensionless tortuosity of the medium. The
porosity is one measure of the dimensions of the internal morphology, usually
in the range 0.2-0.7 (fraction of volume) for polymers, [14]. As stated, the
value of τ is usually between 1 and 100 for other pharmaceutical applications
[14], but in the case of the PLGA τ reaches much larger values, in the range
of 103 − 105, because the drug molecule has to move through some narrow
passageways which are produced by the vibrations of the polymer chain and
control the actual pore size for the passage of macromolecules, [14].
To verify independently the value for the tortuosity, the literature for diffusion
coefficients and effective diffusion coefficients experiments on PLGA spheres
was examined. Batycky et al. [13] obtained the effective diffusivity of a pro-
tein in a PLGA medium: Deff = 2.00× 10
−13[cm2/s] = 2.00× 10−17[m2/s].
Goodhill [24] stated that D0 = 3 × 10
−7[cm2/s] = 3 × 10−11[m2/s] for the
diffusion coefficient of a protein of 17 kD (IL-1 beta). Zhang et al. [14] men-
tion references which published D0 = 8.3 × 10
−11[m2/s] for BSA (bovine
serum albumin). With these values of D0, Deff and p and Expression (4), the
tortuosity τ indeed appears to be of the order of 105.
Fick’s first law can be expressed as the following equation:
J = D
dC
dx
[kg/m2s] or [mol/m2s] (5)
where dC = Csat−0. Zhanf et al. [14] give Csat in the range 1-100 [kg/m
3]. If
the site of the sphere is∆x , then, for very small sizes of the site, such as 10 nm,
the flux J is in the range of 10−8− 10−7[kg/m2s] = 10−26− 10−25[kg/nm2s].
This quantity can be expressed as mass per surface of the site: 10−24− 10−23
[kg/site−surface × s].
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Zhang et al. [14] give an example of concentration saturationC0 = 13.5[kg/m
3] =
13.5 ∗ 10−27[kg/nm3] ≃ 10−24[kg/site]. Thus the time for a site of 10 nm to
reach saturation is t ≃ 10
−24[kg/site]
10−24[kg/(site×s)] ≃ 1s. This means that the time a site
is occupied by a diffusing species is of the order of seconds. In conclusion,
choosing ∆t for the model in the range of seconds should provide realistic sim-
ulations. The physical meaning of the time interval, during which the particles
of the model move, is directly related to the mobility of the particles within the
structure. In the case of a multi-agent model such as the present one, ∆t
does not completely reflect the diffusivity, but rather emerges in the effective
diffusivity of the macromolecule, conditional on the pores of the device.
Choosing much larger time-steps will slow down the release of the particles,
whereas too small time steps will slow down the run-time of the model. Figure
8, (a, b, c) shows how choosing too large a∆t, such as 10 and 20 min, influences
the dissolution profile, making it much slower. The effect of choosing ∆t is
especially visible when the sphere reaches percolation and the molecules gain
mobility.
Spheres have porosity organised in 3 strata, with value decreasing from the
mantle to the core. The simulation indicates more clearly the mechanisms
behind the dissolution profiles. The smaller ∆t is, the more frequently the
particle may update, i.e. move to a neighbouring site with specified probability.
Figure 8, (a, b, c), (t>20 days), shows that in the case where the environment
permits mobility, (right hand side of the graphs), different values for ∆t can
considerably change the rate of dissolution profile.
Figure 8, (a) is a particularly good example: the spheres started at zero initial
porosity, but a small initial burst of particles released can still be observed.
Further, porosity was allowed to increase slowly, (λ=0.00001). At day 16,
when the value of the porosity reaches the threshold value of pth=0.2, the
18 Ana Barat, Martin Crane and Heather J. Ruskin
profiles split according to the different values of ∆t used, and clusters of pores
spanning the whole sphere begin forming at this point in time.
Figures 8, (b) and (c), show release behaviours in steps, due to the sequential
percolation through the three strata by connected pores. The first stratum is
initially percolated and is the origin of the initial burst. The second stratum
is apparently percolated very quickly after dissolution begins, (before day 10),
while the stage, which can be observed by day 20, is caused by a spanning
cluster of pores formed in the last stratum.
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Fig. 8. Effect of the time step ∆t used to perform the updating in the simulation.
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4 Validation with experimental data for quantitative
measurements
Table 1 presents a list of variables, the values of which need to be determined
in order to perform a simulation aiming validation of a model version (several
versions are available for a number of internal configurations of the spheres
[23]), or prediction of the dissolution profile in a given experimental situation.
However, the value of this modelling work is that the framework, once de-
veloped, complements situations, where accurate experimentation is difficult,
since it enables postulation of plausible system values and analysis outcome
over a range, as in the situation of lysozyme release presented in the follow-
ing: The experimental data set referred to here is due to [9] and it relates to
Table 1. Quantities needed for the simulation of protein dissolution from micro-
spheres
Description Variable
Size of the sphere d
Effective diffusivity/mobility of the macromolecules through the pores Deff
Diffusivity of the macromolecules in the solvent D0
Diameter of the macromolecules a
Sphere loading c
Concentration of the macromolecule at different depths of the sphere c01, c02, c03
Size of the pore one wish to consider pd
Initial porosity p0
Pattern of repartition of pores in the volume of the sphere p01, p02, p03
Rate of pore formation λ
a set of nanospheres, encapsulating the lysozyme, a very small protein. The
spheres have been analysed by electron microscopy and they appear compact
and non-porous. This means that the pores, if these exist, have diameter <
20 nm (i.e. below the resolution levels of the microscopy technique [9]). In the
simulations, spheres with no initial pores, as well as spheres with very small
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Table 2. Properties of nanospheres loaded with lysozyme; corresponding modelling
choices taken after evaluation of this data
Variable Value Model
d 200-250 nm 50 sites
Deff N/A ∆t =10min, 1min and 6 sec
D0 N/A not needed here
a ≃3 nm -
c0 1.6% and 6.9% of total weight c0low =0.016 and c0high =0.069
c01 /c02 /c03 N/A c0 /0.5c0/0.2c0
pd >20 nm 5 nm/site
p0 N/A p0low =0 and p0high =0.3
p01 /p02 /p03 N/A p0 /0.3p0 /0
λ N/A 5× 10−6
pores of 5 nm in diameter, just above the Stokes-Einstein diameter of the
lysozyme (3 nm), were considered. Given that the diameter of a site is equal
to the diameter of a pore pd, and the diameter of the sphere is d, the average
size of the sphere is 50 sites. The λ parameter was chosen to be 5× 10−6s−1,
corresponding to a total 55 days of dissolution. Three different values of △t
have been used. It turned out that the non-porous sphere does not generate a
dissolution profile characterised by the significant initial burst, observed ex-
perimentally. The best results were obtained with the porous sphere using the
smallest time step: △t=6 s (as predicted in the previous section). In Figure 9,
(a), the points indicating a slow release experimental curve correspond to an
initial loading of 1.6%, while the curve of very fast release has been obtained
in [9] with an initial loading of 6.9%.
Other slightly larger nanospheres, encapsulating larger proteins, were exam-
ined in the work of Sandor et al. [9] and they were found to have stratified
porosities - larger pores in the mantle and smaller at the core. This is why it
was decided to perform simulations with homogeneous porosity on one hand
and stratified porosities with different configurations of the strata, on the
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other hand. Table 2 shows the best performing strata configuration, as well
as the values for other measured or estimated parameters.
Figure 9, (b) illustrates performance of the model calibrated to simulate re-
lease of carbonic anhydrase from microspheres of size ≃1 µm, described, like
previous spheres, in [9]. More details on this example are available in [23],
which focuses on the importance of correctly modelling the internal mor-
phologies of PLGA spheres.
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Fig. 9. a)Experimental lyzosyme release versus simulated drug release from
biodegradable microspheres. Red rhombi represent the experimental points from
Sandor et al. [9]. Continuous curves show simulated results obtained with different
∆t values. b) Experimental carbonic anhydrase versus simulated drug release from
biodegradable microspheres. Red rhombi represent experimental points [9]. Contin-
uous curves show simulated results obtained with different ∆t values.
5 Conclusion
This paper presents an exploratory framework for modelling dissolution of
proteins from PLGA microspheres. It has been shown that the initial model
can be modified to simulate a number of experimental situations. For the
22 Ana Barat, Martin Crane and Heather J. Ruskin
PLGA microspheres, the results obtained in the work presented above are in
good agreement with experimental work [9]. The models developed can be
easily used to simulate other cases of protein dissolution from PLGA micro-
spheres. Finally, the multi-agent approach permits in-depth exploration of the
problem. Building on the nested levels of complexity in the multi-agent sys-
tem, in a step-by-step way and comparing the results obtained by simulation,
permits the testing of different hypotheses about the system or can be used to
confirm recent experimental work on the inner configuration of the spheres.
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